• C8-2, Optics Valley United Technology City, Gedian Development Zone, Ezhou City, Hubei Province, Chi
  • Ezhou , Hubei, 436000
  • Çin
  • Tel:86 0711-3701120
  • Skype:annwang802
  • Url:

DMAE-NHS CAS NO.115853-74-2

Duz və təmiz natrium xlorid

$ 50 USD / Parça

Yeni

Mövcud deyil

Mövcud deyil

Soruşmaq

Məhsul təsviri

The traditional acridinium ester DMAE-NHS in chemiluminescence belongs to the raw material of flash chemiluminescence reagent, which can be used to label stable labels such as antigens, antibodies, special proteins, DNA, etc., so as to realize the chemiluminescence analysis of biomolecules.

By adopting acridinium ester technology, Desheng produces acridinium ester nsp dmae nhs raw material, CAS115853-74-2, the purity can reach more than 98, the luminescence intensity can reach the maximum at 0.4s, and the luminescence half-life at 0.9s. Its luminescence intensity is 6.11×10 18cps/mol, which is a very stable, highly sensitive and label-specific chemiluminescence reagent raw material.

Acridinium Ester DMAE-NHS in Detail

Acridinium ester DMAE-NHS is a yellow powder, CAS115853-74-2, which can label a variety of antibodies, nucleic acids, proteins, polypeptides, etc. The luminescence data was collected by the instrument.

Advantages of Desheng Acridinium Ester DMAE-NHS Product

Desheng has six different groups of acridine ester, and acridine ester DMAE-NHS introduces a sulfonamide group, which increases steric hindrance and makes hydrolysis better;

Acridinium ester completely eliminates the radioactive hazard, environmental protection and safety. Desheng has a professional R&D team, which is more stable for acridine ester DMAE-NHS batches, and the indicators can be customized;

Desheng acridinium ester DMAE-NHS reagent has a long validity period, and the validity period can last for more than one year. Due to the decay of radioisotopes, the general validity period of radioimmunoassay is one month, and the storage performance of enzyme immunity is poor, and it cannot be compared with chemiluminescence. The longer validity period can reduce the trial cost and facilitate the promotion and application.